Cargando…
Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention
BACKGROUND AND AIMS: The effect of dapagliflozin (DAPA) on the prognosis of patients with acute myocardial infarction (AMI) is unclear. The present study was conducted to evaluate the association between DAPA administration and adverse events in patients with AMI undergoing percutaneous coronary int...
Autores principales: | Zhu, Yi, Zhang, Jia-li, Yan, Xue-jiao, Sun, Ling, Ji, Yuan, Wang, Fang-fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482258/ https://www.ncbi.nlm.nih.gov/pubmed/36114538 http://dx.doi.org/10.1186/s12933-022-01627-0 |
Ejemplares similares
-
Impact of nutritional status on prognosis in acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Kanda, Daisuke, et al.
Publicado: (2022) -
Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction
por: MA, YI, et al.
Publicado: (2013) -
Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions
por: Zhang, Jian-wei, et al.
Publicado: (2014) -
Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Tang, Xiuying, et al.
Publicado: (2022) -
The independent impact of dementia in patients undergoing percutaneous coronary intervention for acute myocardial infarction
por: Kodesh, Afek, et al.
Publicado: (2023)